Veana Therapeutics

$1.4M revenue • 8 employees

Last Updated May 8, 2025

Company Overview

Company Name

Veana Therapeutics

Approx. Annual Revenue

$1.4M

Employees

8

Established

2012

About Veana Therapeutics

Veana Therapeutics is a clinical-stage company dedicated to developing innovative oral medicines for the treatment of cancer. Their technology focuses on selectively targeting and destroying the energy powerhouses (mitochondria) of cancer cells, which stimulates an anti-tumor immune response. Veana is committed to improving and extending the lives of those affected by cancer through effective and safer cancer treatments.

Business Profile

Read from the Veana Therapeutics website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
6/10 · Thin content, no detailed updates; No contact form or booking

Biotech & Life Sciences Companies near OR

Browse all Biotech & Life Sciences companies →

Frequently Asked Questions about Veana Therapeutics

Categories

Social Profiles

Key Decision Makers

Emmanuel Akporiaye Founder and CSO
LinkedIn